Ana1 is a structural component of the centriole required for efficient centriole duplication. No known human homolog (KIAA1731).
| Institute |
|---|
| University of Cambridge |
| SKU: | 151795 |
|---|---|
| Product description: | Ana1 is a structural component of the centriole required for efficient centriole duplication. No known human homolog (KIAA1731). |
| Conjugation: | Unconjugated |
| Isotype: | Isotype: mixed isotypes (ascites purification) |
| Immunogen: | Maltose-binding protein (MBP) fusion proteins |
| Immunogen Uniprot ID: | N/A |
| Cat. #: | 151795 |
|---|---|
| Unit size: | 100 ug |
| Research Fields: | Cell biology |
| Application: | IF ; WB |
| Target: | Drosophila Ana1 |
| Reactivity: | Drosophila |
| Clone: | Ana1 CT |
| Host: | Rabbit |
| Class: | Polyclonal |
| Target background: | Ana1 is a structural component of the centriole required for efficient centriole duplication. No known human homolog (KIAA1731). |
|---|
| Format: | Liquid |
|---|---|
| Shipping conditions: | Dry ice |
| References: |
Stevens et al. 2009. J Cell Biol. 187(3):355-63. PMID: 19948479. Ana3 is a conserved protein required for the structural integrity of centrioles and basal bodies. |
|---|
| Cat. # | Tool Name | |||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 151015 | Anti-CyclinA [E70.1] |
Key Info
Anti-CyclinA [E70.1]
|
View Tool | |||||||||||||||||||
| 151023 | Anti-IL12 [1-1D5] |
Key Info
Anti-IL12 [1-1D5]
|
View Tool | |||||||||||||||||||
| 151031 | Anti-RuvA [RuvA 12C6] |
Key Info
Anti-RuvA [RuvA 12C6]
|
View Tool | |||||||||||||||||||
| 151033 | Anti-HSVUL42 [13C9] |
Key Info
Anti-HSVUL42 [13C9]
|
View Tool | |||||||||||||||||||
| 151034 | Anti-HSVUL42 [13D11] |
Key Info
Anti-HSVUL42 [13D11]
|
View Tool | |||||||||||||||||||
Please note we may take up to three days to respond to your enquiry.
CancerTools.org uses the contact information provided to respond to you about our research tools and service. For more information please review our privacy policy.